PTP4A2
Protein tyrosine phosphatase type IVA 2
Also known as: HU-PP-1, OV-1, PRL-2, PRL2, ptp-IV1a, PTP4A, PTPCAAX2, TP4A2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q12974
- Gene
- PTP4A2
- Ensembl
- ENSG00000184007
- Chromosome
- 1
- Canonical length
- 167 aa
- Protein class
- Enzymes, Predicted intracellular proteins
OverviewNCBI Gene
The protein encoded by this gene belongs to a small class of the protein tyrosine phosphatase (PTP) family. PTPs are cell signaling molecules that play regulatory roles in a variety of cellular processes. PTPs in this class contain a protein tyrosine phosphatase catalytic domain and a characteristic C-terminal prenylation motif. This PTP has been shown to primarily associate with plasmic and endosomal membrane through its C-terminal prenylation. This PTP was found to interact with the beta-subunit of Rab geranylgeranyltransferase II (beta GGT II), and thus may function as a regulator of GGT II activity. Overexpression of this gene in mammalian cells conferred a transformed phenotype, which suggested its role in tumorigenesis. Alternatively spliced transcript variants have been described. Related pseudogenes exist on chromosomes 11, 12 and 17. [provided by RefSeq, Aug 2010]
Canonical amino-acid sequenceUniProt
167 residues, UniProt reviewed canonical sequence.
>Q12974|PTP4A2
1 MNRPAPVEIS YENMRFLITH NPTNATLNKF TEELKKYGVT TLVRVCDATY DKAPVEKEGI
61 HVLDWPFDDG APPPNQIVDD WLNLLKTKFR EEPGCCVAVH CVAGLGRAPV LVALALIECG
121 MKYEDAVQFI RQKRRGAFNS KQLLYLEKYR PKMRLRFRDT NGHCCVQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTP4A2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 456 nTPM
Expression across tissuesHPA
Tissue
- thymus: 456 nTPM
- spinal cord: 290 nTPM
- midbrain: 288 nTPM
- bone marrow: 279 nTPM
- skeletal muscle: 279 nTPM
- hippocampal formation: 226 nTPM
Single-cell type
- platelets: 486 nCPM
- urothelial cells: 327 nCPM
- neutrophils: 281 nCPM
- megakaryocytes: 229 nCPM
- prostatic club cells: 187 nCPM
- prostatic hillock cells: 159 nCPM
Immune cell
- basophil: 205 nTPM
- non-classical monocyte: 149 nTPM
- intermediate monocyte: 106 nTPM
- eosinophil: 88 nTPM
- memory CD8 T-cell: 85 nTPM
- gdT-cell: 75 nTPM
Brain region
- white matter: 662 nTPM
- basal ganglia: 502 nTPM
- midbrain: 435 nTPM
- amygdala: 401 nTPM
- spinal cord: 398 nTPM
- pons: 396 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.28
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 2.07
- DepMap mean gene effect
- -0.29
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PTP4A2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTP4A2 as an antibody target. Whether an autoantibody or antibody against PTP4A2 could matter depends on whether native PTP4A2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTP4A2 is annotated at the cell surface, where native PTP4A2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PTP4A2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...